Prestige Consumer Healthcare Inc. Stock Analysis & AI Score
Prestige Consumer Healthcare Inc. (PBH) has an ST Score of 44.1 (C+), driven by its Profitability (A) and held back by its Growth (D-). Analysts rate it Buy with a $81.67 price target (+78.9% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Medical - Pharmaceuticals |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NYSE |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Prestige Consumer Healthcare Inc. (PBH) has an ST Score of 44.1 (C+), driven by its Profitability (A) and held back by its Growth (D-). Analysts rate it Buy with a $81.67 price target (+78.9% upside).
- Strongest
- ProfitabilityA
- Weakest
- GrowthD-
All factor grades
- ProfitabilityA
- ForecastB
- ValuationC+
- Financial StrengthD+
- MomentumD+
- GrowthD-
- Piotroski5/9
Contact
PBH stock: frequently asked questions
What is PBH's ST Score?
Prestige Consumer Healthcare Inc. (PBH) has an ST Score of 44.1 (C+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is PBH a buy, hold, or sell?
Analysts rate PBH a Buy, with a price target of $81.67 (+78.9% vs the current price). Our ST Score grades it C+ (44.1/100). The ST Score is a data-driven signal, not a recommendation.
What are PBH's factor grades?
Valuation C+, Profitability A, Financial Strength D+, Momentum D+, Growth D-, Forecast B.
What is PBH's valuation grade?
Prestige Consumer Healthcare Inc. (PBH) earns a valuation grade of C+, measured against Medical - Pharmaceuticals peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is PBH's growth grade?
Prestige Consumer Healthcare Inc. (PBH) earns a growth grade of D-, measured against Medical - Pharmaceuticals peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is PBH's profitability grade?
Prestige Consumer Healthcare Inc. (PBH) earns a profitability grade of A, measured against Medical - Pharmaceuticals peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is PBH's financial strength grade?
Prestige Consumer Healthcare Inc. (PBH) earns a financial strength grade of D+, measured against Medical - Pharmaceuticals peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for PBH?
The average analyst price target for Prestige Consumer Healthcare Inc. (PBH) is $81.67 from 17 analysts, which is +78.9% versus the recent price of $45.65.
What is PBH's Piotroski score?
Prestige Consumer Healthcare Inc. (PBH) has a Piotroski F-Score of 5 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.